61908 Federal Register / Vol. 79, No. 199 / Wednesday, October 15, 2014 / Notices 

1Applicants also request relief for future unit 

investment trusts (collectively, with Eaton Vance 

Unit Trust, the ‘‘Trusts’’) and series of the Trusts 

(‘‘Series’’) that are sponsored by EVD or any entity 

controlling, controlled by or under common control 

with EVD (together with EVD, the ‘‘Depositors’’). 

Any future Trust and Series that relies on the 

requested order will comply with the terms and 

conditions of the application. All existing entities 

that currently intend to rely on the requested order 

are named as applicants. 

SUPPLEMENTARY INFORMATION: The 

agenda for the meeting includes the 

following topics: 

—Planetary Science Division Update 

—Planetary Science Division Research 

and Analysis Program Update 

—Reports from Analysis Groups 

It is imperative that the meeting be 

held on this date to accommodate the 

scheduling priorities of the key 

participants. 

Patricia D. Rausch, 

Advisory Committee Management Officer, 

National Aeronautics and Space 

Administration. 

[FR Doc. 2014–24476 Filed 10–14–14; 8:45 am] 

BILLING CODE 7510–13–P 

NUCLEAR REGULATORY 

COMMISSION 

Application for a License To Export 

High-Enriched Uranium 

Pursuant to 10 CFR 110.70(b) ‘‘Public 

Notice of Receipt of an Application,’’ 

please take notice that the Nuclear 

Regulatory Commission (NRC) has 

received the following request for an 

export license. Copies of the request are 

available electronically through ADAMS 

and can be accessed through the Public 

Electronic Reading Room (PERR) link 

http://www.nrc.gov/reading-rm.html at 

the NRC Homepage. 

A request for a hearing or petition for 

leave to intervene may be filed within 

thirty days after publication of this 

notice in the Federal Register. Any 

request for hearing or petition for leave 

to intervene shall be served by the 

requestor or petitioner upon the 

applicant, the office of the General 

Counsel, U.S. Nuclear Regulatory 

Commission, Washington, DC 20555; 

the Secretary, U.S. Nuclear Regulatory 

Commission, Washington, DC 20555; 

and the Executive Secretary, U.S. 

Department of State, Washington, DC 

20520. 

A request for a hearing or petition for 

leave to intervene may be filed with the 

NRC electronically in accordance with 

NRC’s E-Filing rule promulgated in 

August 2007, 72 FR 49139; August 28, 

2007. Information about filing 

electronically is available on the NRC’s 

public Web site at http://www.nrc.gov/

site-help/e-submittals.html. To ensure 

timely electronic filing, at least five days 

prior to the filing deadline, the 

petitioner/requestor should contact the 

Office of the Secretary by email at 

HEARINGDOCKET@NRC.GOV, or by 

calling (301) 415–1677, to request a 

digital ID certificate and allow for the 

creation of an electronic docket. 

In addition to a request for hearing or 

petition for leave to intervene, written 

comments, in accordance with 10 CFR 

110.81, should be submitted within 

thirty days after publication of this 

notice in the Federal Register to Office 

of the Secretary, U.S. Nuclear 

Regulatory Commission, Washington, 

DC 20555, Attention: Rulemaking and 

Adjudications. 

The information concerning this 

application for an export license 

follows. 

NRC EXPORT LICENSE APPLICATION

[Description of material] 

Name of applicant, date of application, date received, application No., 

docket No. 

Material type Total quantity End use Destination 

DOE/NNSA—Y–12 National Security 

Complex, September 18, 2014, 

September 22, 2014, XSNM3756, 

11006175.

High-Enriched Uranium 

(93.35%).

7.28 kilograms uranium235 contained in 7.8 

kilograms uranium.

To fabricate targets at CERCA 

AREVA Romans in France and to 

irradiate targets at the BR–2 Research Reactor in Belgium, the 

HFR Research Reactor in the 

Netherlands, the OSIRIS Research 

Reactor in France, the LVR–15 

Research Reactor in Czech Republic, and the Maria Reactor in 

Poland, for ultimate use for production of medical isotopes at the 

Institute for Radioelements in Belgium.

Belgium. 

For the Nuclear Regulatory Commission. 

Dated this 8th day of October 2014 at 

Rockville, Maryland. 

David L. Skeen, 

Deputy Director, Office of International 

Programs. 

[FR Doc. 2014–24512 Filed 10–14–14; 8:45 am] 

BILLING CODE 7590–01–P 

SECURITIES AND EXCHANGE 

COMMISSION 

[Investment Company Act Release No. 

31280; 812–14304] 

Eaton Vance Distributors, Inc. and 

Eaton Vance Unit Trust; Notice of 

Application 

October 8, 2014. 

AGENCY: Securities and Exchange 

Commission (‘‘Commission’’). 

ACTION: Notice of an application under 

(a) section 6(c) of the Investment 

Company Act of 1940 (‘‘Act’’) for an 

exemption from sections 2(a)(32), 

2(a)(35), 14(a), 19(b), 22(d) and 

26(a)(2)(C) of the Act and rules 19b–1 

and rule 22c–1 thereunder and (b) 

sections 11(a) and 11(c) of the Act for 

approval of certain exchange and 

rollover privileges. 

APPLICANTS: Eaton Vance Distributors, 

Inc. (‘‘EVD’’) and Eaton Vance Unit 

Trust.1

SUMMARY: Summary of Application: 

Applicants request an order to permit 

certain unit investment trusts to: (a) 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 199 / Wednesday, October 15, 2014 / Notices 61909 

Impose sales charges on a deferred basis 

and waive the deferred sales charge in 

certain cases; (b) offer unitholders 

certain exchange and rollover options; 

(c) publicly offer units without requiring 

the Depositor to take for its own account 

$100,000 worth of units; and (d) 

distribute capital gains resulting from 

the sale of portfolio securities within a 

reasonable time after receipt. 

DATES: Filing Dates: The application was 

filed on May 2, 2014 and amended on 

September 2, 2014. 

HEARING OR NOTIFICATION OF HEARING: An 

order granting the application will be 

issued unless the Commission orders a 

hearing. Interested persons may request 

a hearing by writing to the 

Commission’s Secretary and serving 

applicants with a copy of the request, 

personally or by mail. Hearing requests 

should be received by the Commission 

by 5:30 p.m. on November 3, 2014, and 

should be accompanied by proof of 

service on the applicants, in the form of 

an affidavit, or, for lawyers, a certificate 

of service. Hearing requests should state 

the nature of the writer’s interest, the 

reason for the request, and the issues 

contested. Persons who wish to be 

notified of a hearing may request 

notification by writing to the 

Commission’s Secretary. 

ADDRESSES: Brent J. Fields, Secretary, 

Securities and Exchange Commission, 

100 F Street NE., Washington, DC 

20549–1090; Applicants, Two 

International Place, Boston, 

Massachusetts 02110. 

FOR FURTHER INFORMATION CONTACT: 

Aaron T. Gilbride, Attorney-Adviser, at 

(202) 551–6906, or Melissa R. Harke, 

Branch Chief, at (202) 551–6722 

(Division of Investment Management, 

Chief Counsel’s Office). 

SUPPLEMENTARY INFORMATION: The 

following is a summary of the 

application. The complete application 

may be obtained via the Commission’s 

Web site by searching for the file 

number, or an applicant using the 

Company name box, at http://

www.sec.gov/search/search.htm or by 

calling (202) 551–8090. 

Applicants’ Representations 

1. Eaton Vance Unit Trust will be a 

unit investment trust (‘‘UIT’’) that is 

registered under the Act. Any future 

Trust will be a registered UIT. EVD is 

registered under the Securities 

Exchange Act of 1934 as a broker-dealer 

and will be the Depositor of Eaton 

Vance Unit Trust. Each Series will be 

created by a trust indenture between the 

Depositor and a banking institution or 

trust company as trustee (‘‘Trustee’’). 

2. The Depositor acquires a portfolio 

of securities, which it deposits with the 

Trustee in exchange for certificates 

representing units of fractional 

undivided interest in the Series’ 

portfolio (‘‘Units’’). The Units are 

offered to the public through the 

Depositor and dealers at a price which, 

during the initial offering period, is 

based upon the aggregate market value 

of the underlying securities, or, the 

aggregate offering side evaluation of the 

underlying securities if the underlying 

securities are not listed on a securities 

exchange, plus a front-end sales charge, 

a deferred sales charge or both. The 

maximum sales charge may be reduced 

in compliance with rule 22d–1 under 

the Act in certain circumstances, which 

are disclosed in the Series’ prospectus. 

3. The Depositor may, but is not 

legally obligated to, maintain a 

secondary market for Units of an 

outstanding Series. Other broker-dealers 

may or may not maintain a secondary 

market for Units of a Series. If a 

secondary market is maintained, 

investors will be able to purchase Units 

on the secondary market at the current 

public offering price plus a front-end 

sales charge. If such a market is not 

maintained at any time for any Series, 

holders of the Units (‘‘Unitholders’’) of 

that Series may redeem their Units 

through the Trustee. 

A. Deferred Sales Charge and Waiver of 

Deferred Sales Charge Under Certain 

Circumstances 

1. Applicants request an order to the 

extent necessary to permit one or more 

Series to impose a sales charge on a 

deferred basis (‘‘DSC’’). For each Series, 

the Depositor would set a maximum 

sales charge per Unit, a portion of which 

may be collected ‘‘up front’’ (i.e., at the 

time an investor purchases the Units). 

The DSC would be collected 

subsequently in installments 

(‘‘Installment Payments’’) as described 

in the application. The Depositor would 

not add any amount for interest or any 

similar or related charge to adjust for 

such deferral. 

2. When a Unitholder redeems or sells 

Units, the Depositor intends to deduct 

any unpaid DSC from the redemption or 

sale proceeds. When calculating the 

amount due, the Depositor will assume 

that Units on which the DSC has been 

paid in full are redeemed or sold first. 

With respect to Units on which the DSC 

has not been paid in full, the Depositor 

will assume that the Units held for the 

longest time are redeemed or sold first. 

Applicants represent that the DSC 

collected at the time of redemption or 

sale, together with the Installment 

Payments and any amount collected up 

front, will not exceed the maximum 

sales charge per Unit. Under certain 

circumstances, the Depositor may waive 

the collection of any unpaid DSC in 

connection with redemptions or sales of 

Units. These circumstances will be 

disclosed in the prospectus for the 

relevant Series and implemented in 

accordance with rule 22d–1 under the 

Act. 

3. Each Series offering Units subject to 

a DSC will state the maximum charge 

per Unit in its prospectus. In addition, 

the prospectus for such Series will 

include the table required by Form N– 

1A (modified as appropriate to reflect 

the difference between UITs and openend management investment 

companies) and a schedule setting forth 

the number and date of each Installment 

Payment, along with the duration of the 

collection period. The prospectus also 

will disclose that portfolio securities 

may be sold to pay the DSC if 

distribution income is insufficient and 

that securities will be sold pro rata, if 

practicable, otherwise a specific security 

will be designated for sale. 

B. Exchange Option and Rollover 

Option 

1. Applicants request an order to the 

extent necessary to permit Unitholders 

of a Series to exchange their Units for 

Units of another Series (‘‘Exchange 

Option’’) and Unitholders of a Series 

that is terminating to exchange their 

Units for Units of a new Series of the 

same type (‘‘Rollover Option’’). The 

Exchange Option and Rollover Option 

would apply to all exchanges of Units 

sold with a front-end sales charge, a 

DSC or both. 

2. A Unitholder who purchases Units 

under the Exchange Option or Rollover 

Option would pay a lower sales charge 

than that which would be paid for the 

Units by a new investor. The reduced 

sales charge will be reasonably related 

to the expenses incurred in connection 

with the administration of the DSC 

program, which may include an amount 

that will fairly and adequately 

compensate the Depositor and 

participating underwriters and brokers 

for their services in providing the DSC 

program. 

Applicants’ Legal Analysis 

A. DSC and Waiver of DSC 

1. Section 4(2) of the Act defines a 

‘‘unit investment trust’’ as an 

investment company that issues only 

redeemable securities. Section 2(a)(32) 

of the Act defines a ‘‘redeemable 

security’’ as a security that, upon its 

presentation to the issuer, entitles the 

holder to receive approximately his or 


tkelley on DSK3SPTVN1PROD with NOTICES
61910 Federal Register / Vol. 79, No. 199 / Wednesday, October 15, 2014 / Notices 

her proportionate share of the issuer’s 

current net assets or the cash equivalent 

of those assets. Rule 22c–1 under the 

Act requires that the price of a 

redeemable security issued by a 

registered investment company for 

purposes of sale, redemption or 

repurchase be based on the security’s 

current net asset value (‘‘NAV’’). 

Because the collection of any unpaid 

DSC may cause a redeeming Unitholder 

to receive an amount less than the NAV 

of the redeemed Units, applicants 

request relief from section 2(a)(32) and 

rule 22c–1. 

2. Section 22(d) of the Act and rule 

22d–1 under the Act require a registered 

investment company and its principal 

underwriter and dealers to sell 

securities only at the current public 

offering price described in the 

investment company’s prospectus, with 

the exception of sales of redeemable 

securities at prices that reflect 

scheduled variations in the sales load. 

Section 2(a)(35) of the Act defines the 

term ‘‘sales load’’ as the difference 

between the sales price and the portion 

of the proceeds invested by the 

depositor or trustee. Applicants request 

relief from section 2(a)(35) and section 

22(d) to permit waivers, deferrals or 

other scheduled variations of the sales 

load. 

3. Under section 6(c) of the Act, the 

Commission may exempt classes of 

transactions, if and to the extent that 

such exemption is necessary or 

appropriate in the public interest and 

consistent with the protection of 

investors and the purposes fairly 

intended by the policy and provisions of 

the Act. Applicants state that their 

proposal meets the standards of section 

6(c). Applicants state that the provisions 

of section 22(d) are intended to prevent 

(a) riskless trading in investment 

company securities due to backward 

pricing, (b) disruption of orderly 

distribution by dealers selling shares at 

a discount, and (c) discrimination 

among investors resulting from different 

prices charged to different investors. 

Applicants assert that the proposed DSC 

program will present none of these 

abuses. Applicants further state that all 

scheduled variations in the sales load 

will be disclosed in the prospectus of 

each Series and applied uniformly to all 

investors, and that applicants will 

comply with all the conditions set forth 

in rule 22d–1. 

4. Section 26(a)(2)(C) of the Act, in 

relevant part, prohibits a trustee or 

custodian of a UIT from collecting from 

the trust as an expense any payment to 

the trust’s depositor or principal 

underwriter. Because the Trustee’s 

payment of the DSC to the Depositor 

may be deemed to be an expense under 

section 26(a)(2)(C), applicants request 

relief under section 6(c) from section 

26(a)(2)(C) to the extent necessary to 

permit the Trustee to collect Installment 

Payments and disburse them to the 

Depositor. Applicants submit that the 

relief is appropriate because the DSC is 

more properly characterized as a sales 

load. 

B. Exchange Option and Rollover 

Option 

1. Sections 11(a) and 11(c) of the Act 

prohibit any offer of exchange by a UIT 

for the securities of another investment 

company unless the terms of the offer 

have been approved in advance by the 

Commission. Applicants request an 

order under sections 11(a) and 11(c) for 

Commission approval of the Exchange 

Option and the Rollover Option. 

C. Net Worth Requirement 

1. Section 14(a) of the Act requires 

that a registered investment company 

have $100,000 of net worth prior to 

making a public offering. Applicants 

state that each Series will comply with 

this requirement because the Depositor 

will deposit more than $100,000 of 

securities. Applicants assert, however, 

that the Commission has interpreted 

section 14(a) as requiring that the initial 

capital investment in an investment 

company be made without any intention 

to dispose of the investment. Applicants 

state that, under this interpretation, a 

Series would not satisfy section 14(a) 

because of the Depositor’s intention to 

sell all the Units of the Series. 

2. Rule 14a–3 under the Act exempts 

UITs from section 14(a) if certain 

conditions are met, one of which is that 

the UIT invest only in ‘‘eligible trust 

securities,’’ as defined in the rule. 

Applicants state that they may not rely 

on rule 14a–3 because certain Series 

(collectively, ‘‘Equity Series’’) will 

invest all or a portion of their assets in 

equity securities or shares of registered 

investment companies which do not 

satisfy the definition of eligible trust 

securities. 

3. Applicants request an exemption 

under section 6(c) of the Act to the 

extent necessary to exempt the Equity 

Series from the net worth requirement 

in section 14(a). Applicants state that 

the Series and the Depositor will 

comply in all respects with the 

requirements of rule 14a–3, except that 

the Equity Series will not restrict their 

portfolio investments to ‘‘eligible trust 

securities.’’ 

D. Capital Gains Distribution 

1. Section 19(b) of the Act and rule 

19b–1 under the Act provide that, 

except under limited circumstances, no 

registered investment company may 

distribute long-term gains more than 

once every twelve months. Rule 19b– 

1(c), under certain circumstances, 

exempts a UIT investing in eligible trust 

securities (as defined in rule 14a–3) 

from the requirements of rule 19b–1. 

Because the Equity Series do not limit 

their investments to eligible trust 

securities, however, the Equity Series 

will not qualify for the exemption in 

paragraph (c) of rule 19b–1. Applicants 

therefore request an exemption under 

section 6(c) from section 19(b) and rule 

19b–1 to the extent necessary to permit 

capital gains earned in connection with 

the sale of portfolio securities to be 

distributed to Unitholders along with 

the Equity Series’ regular distributions. 

In all other respects, applicants will 

comply with section 19(b) and rule 19b– 

1. 

2. Applicants state that their proposal 

meets the standards of section 6(c). 

Applicants assert that any sale of 

portfolio securities would be triggered 

by the need to meet Trust expenses, 

Installment Payments, or by redemption 

requests, events over which the 

Depositor and the Equity Series do not 

have control. Applicants further state 

that, because principal distributions 

must be clearly indicated in 

accompanying reports to Unitholders as 

a return of principal and will be 

relatively small in comparison to 

normal dividend distributions, there is 

little danger of confusion from failure to 

differentiate among distributions. 

Applicants’ Conditions 

Applicants agree that any order 

granting the requested relief will be 

subject to the following conditions: 

A. DSC Relief and Exchange and 

Rollover Options 

1. Whenever the Exchange Option or 

Rollover Option is to be terminated or 

its terms are to be amended materially, 

any holder of a security subject to that 

privilege will be given prominent notice 

of the impending termination or 

amendment at least 60 days prior to the 

date of termination or the effective date 

of the amendment, provided that: (a) No 

such notice need be given if the only 

material effect of an amendment is to 

reduce or eliminate the sales charge 

payable at the time of an exchange, to 

add one or more new Series eligible for 

the Exchange Option or the Rollover 

Option, or to delete a Series which has 

terminated; and (b) no notice need be 

given if, under extraordinary 

circumstances, either (i) there is a 

suspension of the redemption of Units 

of the Series under section 22(e) of the 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 199 / Wednesday, October 15, 2014 / Notices 61911 

1 15 U.S.C. 78s(b)(1). 

2 17 CFR 240.19b–4. 

3See Securities Exchange Act Release No. 71894 

(Apr. 7, 2014), 79 FR 20273 (‘‘Notice’’). 

4 15 U.S.C. 78s(b)(2). 

5Securities Exchange Act Release No. 72214 (May 

21, 2014), 79 FR 30672 (May 28, 2014). The 

Commission determined that it was appropriate to 

designate a longer period within which to take 

action on the proposed rule change so that it would 

have sufficient time to consider the proposed rule 

change. Accordingly, the Commission designated 

July 10, 2014 as the date by which it should 

approve, disapprove, or institute proceedings to 

determine whether to disapprove the proposed rule 

change. 

6Securities Exchange Act Release No. 72571 (July 

9, 2014), 79 FR 41330 (July 15, 2014). The 

Commission instituted proceedings to allow for 

additional analysis of the proposed rule change’s 

consistency with Section 6(b)(5) of the Act, which 

requires, among other things, that the rules of a 

national securities exchange be ‘‘designed to 

prevent fraudulent and manipulative acts and 

practices, to promote just and equitable principles 

of trade,’’ and ‘‘to protect investors and the public 

interest.’’ See id. 

7See Letter from Christopher S. Jones, Associate 

Professor, University of Southern California to 

Elizabeth M. Murphy, Secretary, Commission (Sept. 

16, 2014). 

8 15 U.S.C. 78s(b)(2). 

9See supra note 3 and accompanying text. 

10 15 U.S.C. 78s(b)(2). 

11 17 CFR 200.30–3(a)(12). 

Act and the rules and regulations 

promulgated thereunder, or (ii) a Series 

temporarily delays or ceases the sale of 

its Units because it is unable to invest 

amounts effectively in accordance with 

applicable investment objectives, 

policies and restrictions. 

2. An investor who purchases Units 

under the Exchange Option or Rollover 

Option will pay a lower sales charge 

than that which would be paid for the 

Units by a new investor. 

3. The prospectus of each Series 

offering exchanges or rollovers and any 

sales literature or advertising that 

mentions the existence of the Exchange 

Option or Rollover Option will disclose 

that the Exchange Option and the 

Rollover Option are subject to 

modification, termination or suspension 

without notice, except in certain limited 

cases. 

4. Any DSC imposed on a Series’ 

Units will comply with the 

requirements of subparagraphs (1), (2) 

and (3) of rule 6c–10(a) under the Act. 

5. Each Series offering Units subject to 

a DSC will include in its prospectus the 

disclosure required by Form N–1A 

relating to deferred sales charges 

(modified as appropriate to reflect the 

differences between UITs and open-end 

management investment companies) 

and a schedule setting forth the number 

and date of each Installment Payment. 

B. Net Worth Requirement 

Applicants will comply in all respects 

with the requirements of rule 14a–3 

under the Act, except that the Equity 

Series will not restrict their portfolio 

investments to ‘‘eligible trust 

securities.’’ 

For the Commission, by the Division of 

Investment Management, under delegated 

authority. 

Kevin M. O’Neill, 

Deputy Secretary. 

[FR Doc. 2014–24423 Filed 10–14–14; 8:45 am] 

BILLING CODE 8011–01–P 

SECURITIES AND EXCHANGE 

COMMISSION 

[Release No. 34–73320; File No. SR– 

NYSEArca–2014–30] 

Self-Regulatory Organizations; NYSE 

Arca, Inc.; Notice of Designation of a 

Longer Period for Commission Action 

on Proceedings To Determine Whether 

To Approve or Disapprove a Proposed 

Rule Change To List and Trade Shares 

of Hull Tactical US ETF Under NYSE 

Arca Equities Rule 8.600 

October 8, 2014. 

On March 24, 2014, NYSE Arca, Inc. 

(‘‘NYSE Arca’’) filed with the Securities 

and Exchange Commission 

(‘‘Commission’’), pursuant to Section 

19(b)(1) of the Securities Exchange Act 

of 1934 (‘‘Act’’) 1 and Rule 19b–4 

thereunder,2 a proposed rule change to 

list and trade shares (‘‘Shares’’) of Hull 

Tactical US ETF under NYSE Arca 

Equities Rule 8.600. The proposed rule 

change was published for comment in 

the Federal Register on April 11, 2014.3

On May 21, 2014, pursuant to Section 

19(b)(2) of the Act,4 the Commission 

designated a longer period within which 

to either approve the proposed rule 

change, disapprove the proposed rule 

change, or institute proceedings to 

determine whether to disapprove the 

proposed rule change.5 On July 9, 2014, 

the Commission instituted proceedings 

to determine whether to approve or 

disapprove the proposed rule change.6

The Commission received one comment 

letter.7

Section 19(b)(2) of the Act 8 provides 

that, after initiating disapproval 

proceedings, the Commission shall issue 

an order approving or disapproving the 

proposed rule change not later than 180 

days after the date of publication of 

notice of filing of the proposed rule 

change. The Commission may extend 

the period for issuing an order 

approving or disapproving the proposed 

rule change, however, by not more than 

60 days if the Commission determines 

that a longer period is appropriate and 

publishes the reasons for such 

determination. The proposed rule 

change was published for notice and 

comment in the Federal Register on 

April 11, 2014.9 The 180th day after 

publication of the notice of the filing of 

the proposed rule change in the Federal 

Register is October 8, 2014, and the 

240th day after publication of the notice 

of the filing of the proposed rule change 

in the Federal Register is December 5, 

2014. 

The Commission finds it appropriate 

to designate a longer period within 

which to issue an order approving or 

disapproving the proposed rule change 

so that it has sufficient time to consider 

the proposed rule change and the 

comment letter received. 

Accordingly, the Commission 

pursuant to 19(b)(2) of the Act 10

designates December 5, 2014 as the date 

by which the Commission shall either 

approve or disapprove the proposed 

rule change (File No. SR–NYSEArca– 

2014–30). 

For the Commission, by the Division of 

Trading and Markets, pursuant to delegated 

authority.11

Kevin M. O’Neill, 

Deputy Secretary. 

[FR Doc. 2014–24421 Filed 10–14–14; 8:45 am] 

BILLING CODE 8011–01–P 

SECURITIES AND EXCHANGE 

COMMISSION 

[Release No. 34–73317; File No. SR– 

ISEGemini–2014–26] 

Self-Regulatory Organizations; ISE 

Gemini Exchange, LLC; Notice of 

Filing and Immediate Effectiveness of 

a Proposed Rule Change To Amend 

Rule 723 To Add a New PIM ISO Order 

Type 

October 8, 2014. 

Pursuant to Section 19(b)(1) of the 

Securities Exchange Act of 1934 


tkelley on DSK3SPTVN1PROD with NOTICES